H-LPLMRKAYL-OH

Ref. 3D-PP46221

Información del producto

• Nombre: H-LPLMRKAYL-OH
• Sinónimos: NH2-Leu-Pro-Leu-Met-Arg-Lys-Ala-Tyr-Leu-OH

Descripción

Peptide H-LPLMRKAYL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LPLMRKAYL-OH include the following: The effect of BK polyomavirus large T antigen on CD4 and CD8 T cells in kidney transplant recipients MR Foroudi, R Yaghobi , A Afshari , J Roozbeh - Transplant , 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0966327422001290 Heterospecific Immunity Help to Sustain an Effective BK-virus Immune Response and Prevent BK-virus-associated Nephropathy M Dekeyser , MGG de Herve , H Hendel-chavez - 2022 - researchsquare.comhttps://www.researchsquare.com/article/rs-1650939/latest Variations in BK polyomavirus immunodominant large tumor antigen-specific 9mer CD8 T-cell epitopes predict altered HLA-presentation and immune failure K Leuzinger, A Kaur, M Wilhelm, HH Hirsch - Viruses, 2020 - mdpi.comhttps://www.mdpi.com/1999-4915/12/12/1476 Reduced Risk of BK Polyomavirus Infection in HLA-B51 Positive Kidney Transplant Recipients JI Rotmans, FHJ Claas, MCW Feltkamp - researchgate.nethttps://www.researchgate.net/profile/Herman-Wunderink/publication/326627018_Reduced_Risk_of_BK_Polyomavirus_Infection_in_HLA-B51_Positive_Kidney_Transplant_Recipients/links/5b96c9dda6fdccfd543e63d4/Reduced-Risk-of-BK-Polyomavirus-Infection-in-HLA-B51-Positive-Kidney-Transplant-Recipients.pdf Cellular immunotherapy for patients with reactivation of JC and BK polyomaviruses after transplantation J Mani, N Jin, M Schmitt - Cytotherapy, 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1465324914005593 T-cell responses to peptide fragments of the BK virus T antigen: implications for cross-reactivity of immune response to JC virus J Li, J Melenhorst, N Hensel - Journal of General , 2006 - microbiologyresearch.orghttps://www.microbiologyresearch.org/content/journal/jgv/10.1099/vir.0.82094-0 Reduced risk of BK polyomavirus infection in HLA-B51-positive kidney transplant recipients HF Wunderink, GW Haasnoot, CS de Brouwer - , 2019 - journals.lww.comhttps://journals.lww.com/transplantjournal/FullText/2019/03000/Reduced_Risk_of_BK_Polyomavirus_Infection_in.29.aspx BK polyomavirus infection after kidney transplantation: risk and prevention HF Wunderink - Transplantation, 2019 - scholarlypublications https://scholarlypublications.universiteitleiden.nl/access/item%3A2978576/download Polyomavirus BK and prostate cancer: a complex interaction of potential clinical relevance EX Keller, S Delbue , M Tognon - Reviews in medical , 2015 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/rmv.1851 UMC Utrecht, Medische Microbiologie, Utrecht Introduction: Broth microdilution (BMD) and, possibly, some automated susceptibility tests are reliable methods BT Franssens, AC Fluit, RJ Rentenaar - nvmm.nlhttps://www.nvmm.nl/media/2062/abstracts_posters_ssm2018.pdf BK polyomavirus-specific antibody and T-cell responses in kidney transplantation: update A Kaur, M Wilhelm, S Wilk - Current opinion in , 2019 - journals.lww.comhttps://journals.lww.com/co-infectiousdiseases/fulltext/2019/12000/bk_polyomavirus_specific_antibody_and_t_cell.9.aspx

• Marca: Biosynth